Aster DM Healthcare Limited , a leading healthcare service provider, has announced its financial results for the first quarter of fiscal year 2026, along with several strategic initiatives to strengthen its market position.

Q1 FY2026 Financial Highlights

Aster DM Healthcare reported a robust performance for the quarter ended June 30, 2025:

• Consolidated revenue from operations increased to INR 1,077.87 crore, up from INR 1,001.87 crore in the same quarter last year, marking a 7.6% year-on-year growth.
• Consolidated profit for the quarter stood at INR 93.56 crore, compared to INR 5,152.20 crore in the previous year's quarter. It's important to note that the prior year's profit included a significant gain from the disposal of business operations.
• On a standalone basis, revenue from operations rose to INR 613.04 crore, up from INR 565.62 crore in Q1 FY2025, showing an 8.4% increase.
• Standalone profit for the quarter was INR 80.59 crore, compared to INR 6,008.24 crore in the same period last year.

Dividend Declaration

The Board of Directors has approved a final dividend of INR 1.00 per equity share for the financial year 2024-25, subject to shareholder approval at the upcoming 17th Annual General Meeting scheduled for September 4, 2025. The record date for dividend eligibility and voting rights has been set for August 28, 2025.

Strategic Expansion and Asset Transfer

Aster DM Healthcare announced several strategic moves to enhance its operational capabilities:

1. Asset Transfer: The company approved the purchase of identified assets of Block D of Aster Whitefield Hospital from its wholly-owned subsidiary, Aster DM Multispecialty Hospital Private Limited (AMHPL), for a consideration not exceeding INR 80.00 crore. This transfer is aimed at operational and strategic optimization.

2. Increased Stake in Subsidiary: The company is set to acquire an additional 13% stake in Dr. Ramesh Cardiac & Multispecialty Hospital Pvt Ltd (DRCM), increasing its shareholding from 57.49% to 70.49%. This acquisition, valued at INR 63.01 crore, is in line with the put option exercised by DRCM's promoter group.

3. New Hospital Project: Aster DM Healthcare has entered into a lease agreement for a composite property in Yeshwanthpur, Bengaluru, to establish a new 500-bed super-specialty hospital. The project, with an estimated investment of INR 580.00 crore, is expected to be operational in the second half of FY 2028-29.

Corporate Governance Updates

The company has also amended several policies, including those related to related party transactions, materiality disclosures, and insider trading, reinforcing its commitment to strong corporate governance practices.

Dr. Azad Moopen, Chairman and Managing Director of Aster DM Healthcare, commented on the results, stating, "Our Q1 performance demonstrates the resilience of our business model and the success of our strategic initiatives. The expansion plans and operational optimizations we've announced today are aimed at strengthening our market position and enhancing shareholder value."

As Aster DM Healthcare continues to expand its footprint and optimize operations, investors and stakeholders will be keenly watching the company's progress in executing these strategic initiatives and their impact on future financial performance.

Aster DM Healthcare , a leading healthcare provider, has made significant moves to strengthen its position in the Indian healthcare market. The company has increased its stake in a subsidiary and announced plans for a new super-specialty hospital in Bengaluru.

Acquisition of Additional Stake in Dr. Ramesh Cardiac & Multispecialty Hospital

Aster DM Healthcare has acquired an additional 13% stake in its subsidiary, Dr. Ramesh Cardiac & Multispecialty Hospital Pvt Ltd (DRCM), for INR 63.01 crores. This acquisition increases Aster's shareholding in DRCM from 57.49% to 70.49%. The transaction follows the exercise of a put option by DRCM's promoter group under a shareholders agreement dating back to April 2016.

DRCM, established in 1995 and based in Vijayawada, has shown strong financial performance. For the fiscal year ending March 31, DRCM reported:

The acquisition is expected to be completed within the next 1-2 months and does not require any governmental or regulatory approvals.

New Super-Specialty Hospital in Bengaluru

In a separate development, Aster DM Healthcare has approved a 30-year lease agreement with KEMWELL Private Limited for a property in Yeshwanthpur, Bengaluru. This strategic move aims to establish a 500-bed super-specialty hospital in the area.

Key details of the project include:

• Investment: INR 580 crores, to be funded through bank loans and internal accruals
• Expected Operations Start: Second half of FY 2028-29
• Location: Yeshwanthpur, a rapidly developing corridor in northwest Bengaluru
• Connectivity: Excellent metro and railway connectivity

The new hospital is designed to serve the growing healthcare needs in the Yeshwanthpur area, which is experiencing increasing demand for advanced tertiary healthcare services.

Expanding Footprint

These developments are part of Aster DM Healthcare's strategy to expand its presence in key markets. The company's existing capacity stands at 5,159 beds as of March 31, with an occupancy rate of 65%. The addition of the 500-bed facility in Bengaluru represents a significant expansion of the company's healthcare infrastructure.

Aster DM Healthcare's Investment and Finance Committee approved these decisions in a meeting held on July 30. The company expects these strategic moves to strengthen its position in the healthcare sector and cater to the increasing demand for quality healthcare services in India.

As the healthcare landscape continues to evolve, Aster DM Healthcare's expansion plans demonstrate its commitment to growth and improved healthcare accessibility in key Indian markets.